PALO ALTO, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Bruce Cozadd, Chairman and CEO, will present a corporate overview, discuss financial results, and provide 2010 guidance at the 28th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2010 at 11:00 a.m. PST at The Westin St. Francis in San Francisco.
A webcast of the presentation may be accessed by visiting http://metameetings.com/webcasts/jpmorgan/healthcare10/directlink?ticker=JAZZ, and after the presentation, the slides may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. The webcast and the slides will be available for two weeks following the presentation.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information please see www.jazzpharmaceuticals.com.
SOURCE Jazz Pharmaceuticals, Inc.